{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:09:16Z","timestamp":1789463356722,"version":"build-2803163510"},"reference-count":58,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Tau positron emission tomography (PET) has become a central imaging modality for in vivo detection and quantification of tau pathology across the Alzheimer's disease (AD) clinical and biological continuum. [18F]-Florzolotau is a second-generation tau PET tracer developed to improve target-to-background contrast and mitigate off-target binding relative to first-generation ligands, thereby improving interpretability for translational research and clinical use. In this narrative review, we provide a critical appraisal of the available literature on [18F]-Florzolotau PET imaging in AD, with emphasis on diagnostic and differential-diagnostic performance, the spatiotemporal topography of tau deposition in relation to Braak staging and disease progression, and the clinical significance of tracer uptake with respect to cognitive measures, disease severity, and prognosis. Eligible studies were clinical investigations published between 2020 and 2025 that applied [18F]-Florzolotau PET in cohorts spanning cognitively unimpaired individuals through symptomatic AD stages. Across reports, [18F]-Florzolotau PET differentiated AD dementia from cognitively unimpaired comparators with high accuracy, with sensitivities \u2265 90% and specificities of 87\u201396%. Regional uptake patterns were broadly consistent with Braak-like propagation, progressing from medial temporal regions toward associative neocortex in parallel with increasing clinical severity. Quantitative tracer uptake also correlated with global cognition and key domains, including episodic memory and executive function. We conclude that [18F]-Florzolotau PET provides a robust in vivo measure of AD tau burden, motivating further evaluation for diagnostic and prognostic applications. Larger multicenter studies with harmonized acquisition\/quantification and head-to-head comparisons versus other second-generation tracers remain priorities.<\/jats:p>","DOI":"10.1177\/13872877261469867","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:06:35Z","timestamp":1785247595000},"page":"578-592","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["[18F]-florzolotau PET imaging in Alzheimer's disease: Current evidence and future directions"],"prefix":"10.1177","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-7858","authenticated-orcid":false,"given":"Simone","family":"Lista","sequence":"first","affiliation":[{"name":"i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piercarlo","family":"Minoretti","sequence":"additional","affiliation":[{"name":"General Direction, Studio Minoretti, Oggiono, Lecco, Italy"},{"name":"Miguel de Cervantes European University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-0290","authenticated-orcid":false,"given":"Enzo","family":"Emanuele","sequence":"additional","affiliation":[{"name":"Scientific Directorate, 2E Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-8239","authenticated-orcid":false,"given":"Susana","family":"L\u00f3pez-Ortiz","sequence":"additional","affiliation":[{"name":"i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing-Tsung","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Linkou Chang Gung Memorial Hospital"},{"name":"Department of Medical Imaging and Radiological Sciences and Healthy Aging Research Center, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Merino-Pa\u00eds","sequence":"additional","affiliation":[{"name":"i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-806X","authenticated-orcid":false,"given":"Camillo","family":"Imbimbo","sequence":"additional","affiliation":[{"name":"University of Pavia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy Ylenia","family":"Cisale","sequence":"additional","affiliation":[{"name":"Sapienza University of Rome"},{"name":"Department of Neurorehabilitation, IRCCS San Raffaele Pisana, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Garaci","sequence":"additional","affiliation":[{"name":"University of Rome Tor Vergata"},{"name":"San Raffaele Cassino, Cassino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-7262","authenticated-orcid":false,"given":"Bruno P.","family":"Imbimbo","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Chiesi Farmaceutici, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Santos-Lozano","sequence":"additional","affiliation":[{"name":"i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University (UEMC), Valladolid, Spain"},{"name":"Research Institute of the Hospital 12 de Octubre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chen","family":"Yen","sequence":"additional","affiliation":[{"name":"APRINOIA Therapeutics, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"e_1_3_3_2_2","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022; 7: e105\u2013e125.","journal-title":"Lancet Public Health"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00265"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.225"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells14191506"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2174\/0115672050301407240408033046"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170176"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30585-0"},{"key":"e_1_3_3_9_2","article-title":"Tau accumulation and its spatial progression across the Alzheimer\u2019s disease spectrum","volume":"6","author":"St-Onge F","year":"2024","unstructured":"St-Onge F, Chapleau M, Breitner JCS, et al. Tau accumulation and its spatial progression across the Alzheimer\u2019s disease spectrum. Brain Commun 2024; 6: fcae031.","journal-title":"Brain Commun"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.164848"},{"key":"e_1_3_3_11_2","article-title":"The role of 18F-flortaucipir (AV-1451) in the diagnosis of neurodegenerative disorders","volume":"13","author":"Roy S","year":"2021","unstructured":"Roy S, Banerjee D, Chatterjee I, et al. The role of 18F-flortaucipir (AV-1451) in the diagnosis of neurodegenerative disorders. Cureus 2021; 13: e16644.","journal-title":"Cureus"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.139550"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265200"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04305-8"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-019-01344-x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww098"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0342-8"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2015.08.006"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003164"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70078"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2025.134649"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.09.042"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/agt2.70133"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01875-2"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-023-01828-x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13342-3"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1148054"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07539-x"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/13872877251372523"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2025.112113"},{"key":"e_1_3_3_31_2","article-title":"Role of 18F-florzolotau PET in diagnostic and therapeutic decision-making for cognitive impairment","volume":"21","author":"Wang J","year":"2025","unstructured":"Wang J, Wang ZY, Chen SF, et al. Role of 18F-florzolotau PET in diagnostic and therapeutic decision-making for cognitive impairment. Alzheimers Dement 2025; 21: e70563.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_3_32_2","article-title":"Divergent effects of age on imaging-based ATN biomarkers and cognition in Alzheimer\u2019s disease","volume":"17","author":"Frings L","year":"2025","unstructured":"Frings L, Hellwig S, Brumberg J, et al. Divergent effects of age on imaging-based ATN biomarkers and cognition in Alzheimer\u2019s disease. Alzheimers Dement (Amst) 2025; 17: e70142.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2025.111343"},{"key":"e_1_3_3_34_2","article-title":"Clinical characteristics and biomarker profile in early- and late-onset Alzheimer\u2019s disease: the Shanghai Memory Study","volume":"7","author":"Wu J","year":"2025","unstructured":"Wu J, Wang J, Xiao Z, et al. Clinical characteristics and biomarker profile in early- and late-onset Alzheimer\u2019s disease: the Shanghai Memory Study. Brain Commun 2025; 7: fcaf015.","journal-title":"Brain Commun"},{"key":"e_1_3_3_35_2","article-title":"The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer\u2019s disease and tau burden","volume":"21","author":"Huang KL","year":"2025","unstructured":"Huang KL, Hsiao IT, Huang CW, et al. The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer\u2019s disease and tau burden. Alzheimers Dement 2025; 21: e14297.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13680"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2024.120593"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.26689"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-230581"},{"key":"e_1_3_3_40_2","first-page":"1000","article-title":"Altered brain energy metabolism related to astrocytes in Alzheimer\u2019s disease","volume":"94","author":"Hirata K","year":"2023","unstructured":"Hirata K, Matsuoka K, Tagai K, et al. Altered brain energy metabolism related to astrocytes in Alzheimer\u2019s disease. Ann Neurol 2023; 94: 1000\u20131012.","journal-title":"Ann Neurol"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00365-x"},{"key":"e_1_3_3_42_2","article-title":"Centaur: toward a universal scale and masks for standardizing tau imaging studies","volume":"15","author":"Villemagne VL","year":"2023","unstructured":"Villemagne VL, Leuzy A, Bohorquez SS, et al. Centaur: toward a universal scale and masks for standardizing tau imaging studies. Alzheimers Dement (Amst) 2023; 15: e12454.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-09571-7"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103416"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004663"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29338"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201389"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119763"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12101355"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29173"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.789054"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.598234"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00604"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263196"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51689"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05401-4"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2024.108986"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117193"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00166"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261469867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877261469867","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261469867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:09:53Z","timestamp":1789459793000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877261469867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/13872877261469867"],"URL":"https:\/\/doi.org\/10.1177\/13872877261469867","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}